Medical Properties On Buyout Spree, Acquires 30 UK Hospitals
Zacks Investment Research | Jan 09, 2020 08:39PM ET
Medical Properties Trust, Inc. (NYSE:MPW) , also called MPT, recently completed the purchase of real estate interests in 30 U.K. acute care hospital facilities. The deal, announced on Dec 23, 2019, involved an approximate investment of £1.5 billion ($2 billion).
At the time of announcement, the company had planned to fund the transaction with cash in hand, including capital raised from the U.S. dollar equity offering along with sterling-denominated bond offerings and amounts borrowed under an unsecured sterling-denominated term loan facility.
Buyout Rationale
The transaction is likely to prove immediately accretive to the funds from operation (FFO) per share. The properties, which are leased under long-term net leases to affiliates of a renowned private operator of acute hospitals, BMI Healthcare, are likely to provide a yield of 8.9% on a GAAP basis.
Moreover, the buyout will increase MPT’s total gross assets to nearly $16.2 billion, thus, lowering the company’s tenant concentration drastically. Given the rising senior citizen population, the U.K. is witnessing growing demand for healthcare properties. Driven by such favorable factors, the healthcare REIT’s deal to expand its footprint in the country seems strategic.
Conclusion
MPT’s continuous efforts to diversify its presence in the U.S. and U.K. markets well position it to benefit from the demographic trends in the regions. In line with the efforts, the REIT is on a buyout-spree, investing significant amounts in acute care hospitals.
In November 2019, MPT announced an agreement to take over 10 acute care hospitals in six U.S. states from the affiliates of LifePoint Health, Inc. for $700 million. The deal is likely to close in the current quarter.
Last August, the company closed two more deals. These added eight U.K. hospitals operated by Ramsay Health Care and 16 operated by Prospect Medical Holdings, Inc.
Shares of this Zacks Rank #2 (Buy) company have rallied 27.6% in the past year, outperforming the Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.